Citations

Showing 10 of 108081 citations.

2SDP-04 The nature of myocardial heart failure : Are hypertrophic cardiomyopathies all the same?(2SDP ASB-BSJ Bilateral Symposium 2013,Symposium,The 51th Annual Meeting of the Biophysical Society of Japan)
Li, Amy , King, Dane, Bos, Martijn, Kable, Eleanor , Ishiwata, Shin’ichi , Ackerman, Michael J. , Kekic, Murat, Macdonald, Peter S , Braet, Filip , Hambly, Brett David , Remedios, Cristobal G. dos

Mayo Clinic

Seibutsu Butsuri | May 5, 2017 | Volume: 53 | Issue: supplement1-2 | Pages: S99

10.2142/biophys.53.s99_4 Get It

V̇o2 kinetics associated with moderate-intensity exercise in heart failure: impact of intrathecal fentanyl inhibition of group III/IV locomotor muscle afferents
Iterson, Erik H. Van , Johnson, Bruce D. , Joyner, Michael J. , Curry, Timothy B. , Olson, Thomas P. , Van Iterson, Erik H , Joyner, Michael J

Mayo Clinic

American Journal of Physiology-Heart and Circulatory Physiology | May 5, 2017 | Volume: 313 | Issue: 1 | Pages: H114-H124

10.1152/ajpheart.00014.2017 | PMID 28476919 Get It

Heart failure (HF) patients demonstrate impaired pulmonary, circulatory, and nervous system responses to exercise. While HF demonstrates prolonged [time constant (τ)] pulmonary O2 uptake (V̇o2) on-kinetics, contributing to exercise intolerance, it is unknown whether abnormal V̇o2 kinetics couple with ventilatory and circulatory dysfunction secondary to impaired group III/IV afferents in HF. Because lower lumbar intrathecal fentanyl inhibits locomotor muscle afferents, resulting in improved exercise ventilation and hemodynamics, we tested these hypotheses: HF will demonstrate 1) rapid V̇o2 on-kinetics and 2) attenuated steady-state V̇o2 amplitude and O2 deficit (O2def) during exercise with fentanyl versus placebo. On separate visits (randomized), breath-by-breath V̇o2 was measured in HF (ejection fraction: 27 ± 6%, New York Heart Association class I–III) and age- and sex-matched controls (both n = 9, ages: 60 ± 6 vs. 63 ± 8 yr, P = 0.37) during cycling transitions at 65% peak workload (78 ± 24 vs. 115 ± 39 W, P < 0.01) with intrathecal fentanyl or placebo. Regardless of group or condition, optimal phase II (primary component) curve fits reflected a phase I period equal to 35 s (limb-to-lung timing) via single-exponential functions. Condition did not affect steady-state V̇o2, the phase II τ of V̇o2, or O2def within controls ( P > 0.05). Without differences in steady-state V̇o2, reduced O2def in fentanyl versus placebo within HF (13 ± 4 vs. 22 ± 15 ml/W, P = 0.04) was accounted for by a rapid phase II τ of V̇o2 in fentanyl versus placebo within HF (45 ± 11 vs. 57 ± 14 s, P = 0.04), respectively. In an integrative manner, these data demonstrate important effects of abnormal locomotor muscle afferents coupled to pulmonary and circulatory dysfunction in determining impaired exercise V̇o2 in HF. Effects of abnormal muscle afferents on impaired exercise V̇o2 and hence exercise intolerance may not be discernable by independently assessing steady-state V̇o2 in HF. NEW & NOTEWORTHY Inhibition of locomotor muscle afferents results in rapid primary-component O2 uptake (V̇o2) on-kinetics accounting for the decreased O2 deficit in heart failure (HF). This study revealed that abnormal musculoskeletal–neural afferents couple with pulmonary and circulatory dysfunction to provoke impaired exercise V̇o2 in HF. Steady-state V̇o2 cannot properly phenotype abnormal muscle afferent contributions to impaired exercise V̇o2 in HF.
Comparative quality assessment of esophageal examination with transnasal and sedated endoscopy
Crews, Nicholas R. , Gorospe, Emmanuel C., Johnson, Michele L., Song, Louis–Michel Wong Kee, Katzka, David A. , Wong Kee Song, Louis-Michel, Iyer, Prasad G. , Iyer, Prasad

Mayo Clinic

Endoscopy International Open | May 5, 2017 | Volume: 05 | Issue: 05 | Pages: E340-E344

10.1055/s-0042-122008 | PMID 28484734 Get It

Abstract Background Unsedated transnasal esophagoscopy (TNE) may offer a less expensive, mobile alternative to sedated esophagogastroduodenoscopy (EGD) for evaluations of reflux related complications. Comparisons of imaging quality by these methods are lacking. Methods Two reviewers evaluated videos of TNE and EGD procedures, performed during a community randomized study comparing endoscopic techniques. Subjects were randomized to EGD, TNE in endoscopy suite, or TNE in mobile research unit. Endoscopic quality was assessed using a validated scoring tool. Results In total, 115 videos (58 EGD, 28 endoscopy suite TNE, and 29 mobile TNE) were reviewed. Overall quality scores for TNE and EGD were excellent without a statistically significant difference (P = 0.30). There were no differences in gastroesophageal junction (GEJ) visualization scores, though EGD scored higher in esophageal passage (P < 0.05) and TNE scored higher in esophageal intubation (P < 0.05). There was no significant difference in any quality score between mobile TNE and gastrointestinal suite TNE. Conclusion Esophageal assessment with TNE or EGD was comparable in overall quality and GEJ visualization. TNE quality was not affected by procedure location. TNE is a feasible option for endoscopic assessment of reflux complications.
Does the trait anxiety affect the dental fear?
Doğaner, Yusuf Çetin , Aydoğan, Ümit , YESIL, Hande Ucler , Rohrer, James E. , Williams, Mark Douglas, Agerter, David C., Agerter, David Charles

Mayo Clinic

Brazilian Oral Research | May 5, 2017 | Volume: 31 | Pages: No page available

10.1590/1807-3107bor-2017.vol31.0036 | PMID 28513787 Get It

Editorial: risk factors for persistent villus atrophy in coeliac disease – is it time to reconsider definitions for refractory coeliac disease? Authors' reply
Mahadev, SriHari , Green, P. H. R., Adelman, Donna, Lebwohl, Benjamin , Mahadev, S , Murray, Joseph A.

Mayo Clinic

Alimentary Pharmacology & Therapeutics | May 5, 2017 | Volume: 45 | Issue: 11 | Pages: 1478-1479

10.1111/apt.14086 | PMID 28474831 Get It

Linked ContentThis article is linked to Mahadev et al and Braude, Newnham papers. To view these articles visit https://doi.org/10.1111/apt.13988 and https://doi.org/10.1111/apt.14055.
Pittsburgh compound-B PET white matter imaging and cognitive function in late multiple sclerosis
Zeydan, Burcu , Lowe, Val J. , Przybelski, Scott A. , Tosakulwong, Nirubol , Zuk, Samantha M., Senjem, Matthew L. , Gunter, Jeffrey L. , Roberts, Rosebud O., Mielke, Michelle M. , Benarroch, Eduardo E. , Rodriguez, Moses , Lesnick, Timothy G. , Petersen, Ronald C. , Jack, Clifford R. , Kantarci, Kejal , Kantarci, Orhun H. , Schwarz, Christopher G. , Machulda, Mary M. , Knopman, David S. , Jack, Clifford R , Mielke, Michelle M , Senjem, Matthew L , Kantarci, Kejal , Rodriguez, Moses , Zeydan, Burcu

Mayo Clinic

Multiple Sclerosis Journal | May 5, 2017 | Volume: 24 | Issue: 6 | Pages: 739-749

10.1177/1352458517707346 | PMID 28474977 Get It

Background: There is growing interest in white matter (WM) imaging with positron emission tomography (PET). Objectives: We studied the association of cognitive function in late multiple sclerosis (MS) with cortical and WM Pittsburgh compound-B PET (PiB-PET) binding. Methods: In the population-based Mayo Clinic Study of Aging, 24 of 4869 participants had MS (12 underwent PiB-PET). Controls were age and sex matched (5:1). We used automated or semi-automated processing for quantitative image analyses and conditional logistic regression for group differences. Results: MS patients had lower memory ( p = 0.03) and language ( p = 0.02) performance; smaller thalamic volumes ( p = 0.003); and thinner temporal ( p = 0.001) and frontal ( p = 0.045) cortices on magnetic resonance imaging (MRI) than controls. There was no difference in global cortical PiB standardized uptake value ratios between MS and controls ( p = 0.35). PiB uptake was lower in areas of WM hyperintensities compared to normal-appearing white matter (NAWM) in MS ( p = 0.0002). Reduced PiB uptake in both the areas of WM hyperintensities ( r = 0.65; p = 0.02) and NAWM ( r = 0.69; p = 0.01) was associated with decreased visuospatial performance in MS. Conclusion: PiB uptake in the cortex in late MS is not different from normal age-matched controls. PiB uptake in the WM in late MS may be a marker of the large network structures’ integrity such as those involved in visuospatial performance.
Outcome of elderly patients after failure to hypomethylating agents given as frontline therapy for acute myeloid leukemia: Single institution experience*
Nanah, Rama , McCullough, Kristen , Begna, Kebede H. , Patnaik, Mrinal M. , Elliott, Michelle A. , Litzow, Mark R. , Al‐Kali, Aref , Hogan, William, Patnaik, Mrinal , Hogan, William J. , McCullough, Kristen B

Mayo Clinic

American Journal of Hematology | May 5, 2017 | Volume: 92 | Issue: 9 | Pages: 866-871

10.1002/ajh.24780 | PMID 28474744 Get It

Outcomes of acute myeloid leukemia (AML) in elderly patients unfit for intensive chemotherapy is challenging. Hypomethylating agents (HMAs) can be effective in these patients but responses are usually short‐lived. The majority of patients will either have stable disease or progress through therapy. We hereby describe the outcome of these patients at our institution after they fail HMAs. The data on 56 AML patients at Mayo Clinic, Rochester were reviewed. Patients were considered for our study if they received HMA as frontline therapy for their AML. Out of 56 patients, 15 (27%) patients received azacitidine (AZA) and 41 (73%) received decitabine. Complete remission was found in 10 (18%), with overall response of 28% and median response duration of 10 months. Thirteen (81%) out of 16 responders relapsed. Therefore 53 patients were included in the primary or secondary failure analysis with a median overall survival (OS) of 2 months after the date of failure. Out of 53 patients, 12 (23%) received subsequent treatments. None of the 12 patients who got first salvage therapy achieved remission. Five out of the 12 patients received second salvage therapy, 2 (40%) of which achieved CR. Median OS for patients who received subsequent salvage therapies was better than those who did not receive any subsequent therapy after failing HMA (9.5 vs. 2 months, P = .0009). Outcome for patients who have primary or secondary failure is very poor. Our study provides important historical data for future novel therapies, which are sorely needed for these patients.
Low rates of contralateral neck failure in unilaterally treated oropharyngeal squamous cell carcinoma with prospectively defined criteria of lateralization
Hu, Kenneth S. , Gamez, Mauricio E. , Safdieh, Joseph, Lin, Wilson, Jacobson, A. , Urken, Mark L. , Culliney, B., Li, Zujun, Tran, Theresa , Schantz, Stimson P., Chadha, Juskaran , Harrison, Louis B., Hu, Kenneth Shung , Gamez, Mauricio , Mourad, Waleed Fouad , Persky, Mark Stephen

Mayo Clinic

Head & Neck | May 5, 2017 | Volume: 39 | Issue: 8 | Pages: 1647-1654

10.1002/hed.24806 | PMID 28474380 Get It

AbstractBackgroundUnilateral radiotherapy (RT) of oropharyngeal carcinomas is accepted for patients with lateralized primary and low‐volume nodal disease. Utilizing prospectively defined criteria of laterality and staging positron emission tomography (PET)/CT, we studied outcomes in patients with advanced‐stage oropharyngeal cancer undergoing unilateral RT.MethodsThirty‐seven patients with oropharyngeal tumors >1 cm from midline regardless of node status underwent unilateral RT and were followed prospectively. Patient characteristics: T1 = 11; T2 = 22; T3 = 4; N0 = 3; N1 = 9; N2a = 3; N2b = 21; and Nx = 1. Dosimetry were determined and weekly National Comprehensive Cancer Network (NCCN) distress thermometer data were collected.ResultsAt median follow‐up of 32 months, 3‐year locoregional control, contralateral regional failure, distant metastasis‐free survival, and disease‐free survival were 96%, 0%, 7%, and 93%, respectively.ConclusionLow rates of contralateral neck failure are demonstrated utilizing prospectively defined criteria for unilateral RT. The tolerances of contralateral organs are respected and patients report low to moderate levels of distress throughout treatment.
TNFα decreases mitochondrial movement in human airway smooth muscle
Delmotte, Philippe , Zavaletta, Vanessa A., Prakash, Y. S. , Sieck, Gary C. , Prakash, Y S , Thompson, Michael A. , Sieck, Gary

Mayo Clinic

American Journal of Physiology-Lung Cellular and Molecular Physiology | May 5, 2017 | Volume: 313 | Issue: 1 | Pages: L166-L176

10.1152/ajplung.00538.2016 | PMID 28473328 Get It

In airway smooth muscle (ASM) cells, excitation-contraction coupling is accomplished via a cascade of events that connect an elevation of cytosolic Ca2+concentration ([Ca2+]cyt) with cross-bridge attachment and ATP-consuming mechanical work. Excitation-energy coupling is mediated by linkage of the elevation of [Ca2+]cytto an increase in mitochondrial Ca2+concentration, which in turn stimulates ATP production. Proximity of mitochondria to the sarcoplasmic reticulum (SR) and plasma membrane is thought to be an important mechanism to facilitate mitochondrial Ca2+uptake. In this regard, mitochondrial movement in ASM cells may be key in establishing proximity. Mitochondria also move where ATP or Ca2+buffering is needed. Mitochondrial movement is mediated through interactions with the Miro-Milton molecular complex, which couples mitochondria to kinesin motors at microtubules. We examined mitochondrial movement in human ASM cells and hypothesized that, at basal [Ca2+]cytlevels, mitochondrial movement is necessary to establish proximity of mitochondria to the SR and that, during the transient increase in [Ca2+]cytinduced by agonist stimulation, mitochondrial movement is reduced, thereby promoting transient mitochondrial Ca2+uptake. We further hypothesized that airway inflammation disrupts basal mitochondrial movement via a reduction in Miro and Milton expression, thereby disrupting the ability of mitochondria to establish proximity to the SR and, thus, reducing transient mitochondrial Ca2+uptake during agonist activation. The reduced proximity of mitochondria to the SR may affect establishment of transient “hot spots” of higher [Ca2+]cytat the sites of SR Ca2+release that are necessary for mitochondrial Ca2+uptake via the mitochondrial Ca2+uniporter.